The Wnt signaling pathway and rheumatoid arthritis

Autoimmunity Reviews

Volumn 9, Issue 4, 2010, Pages 207-210

  Rabelo, Francieli de Sousa ^a   da Mota, Licia Maria Henrique ^a   Lima, Rodrigo Aires Corrêa ^a   Lima, Francisco Aires Corrêa ^a   Barra, Gustavo Barcelos ^b   de Carvalho, Jozélio Freire ^c   Amato, Angélica Amorim ^a  

^a University Hospital of Brasilia   (Brazil)

^b Sabin Institute and Laboratory of Clinical Analysis   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Frizzled receptors; Rheumatoid arthritis; Wnt proteins

Indexed keywords

BETA CATENIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; OSTEOCALCIN; OSTEOPROTEGERIN; PROTEIN KINASE C; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN;

CARTILAGE CELL; CLINICAL FEATURE; EMBRYO DEVELOPMENT; GENETIC POLYMORPHISM; HUMAN; LIMB DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; FRIZZLED RECEPTORS; HUMANS; NF-KAPPA B; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANS-ACTIVATORS; WNT PROTEINS;

EID: 73649146567     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.08.003     Document Type: Review

References (40)

1. Keen H.I., and Emery P. How should we manage early rheumatoid arthritis? From imaging to intervention. Curr Opin Rheumatol 17 3 (2005) 280-285
2. Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 21 (2003) S71-S74
3. Tedesco A., D Agostino D., Soriente I., et al. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev 8 3 (Jan 2009) 233-237 Electronic publication 2008 Aug 15
4. Senolt L., Vencovský J., Pavelka K., Ospelt C., and Gay S. Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev (Mar 26 2009) [Electronic publication ahead of print]
5. Caporali R., Pallavicini F.B., Filippini M., et al. Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal. Autoimmun Rev 8 3 (Jan 2009) 274-280 Electronic publication 2008 Nov 17
6. Rijsewijk F., Schuermann M., Wagenaar E., Parren P., Weigel D., and Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50 4 (1987) 649-657
7. Nusse R., and Varmus H.E. Many tumors induced by the mouse mammary tumor virus contains a provirus integrated in the same region of the host genome. Cell 31 (1982) 99-109
8. Johnson M.L., and Kamel M.A. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19 (2007) 376-382
9. Sen M. Wnt signalling in rheumatoid arthritis. Rheumatology 44 (2005) 708-713
10. Veeman M.T., Axelrod J.D., and Moon R.T. A second canon: functions and mechanisms of -catenin independent Wnt signaling. Dev Cell 5 (2003) 367-377
11. Povelones M., Howes R., Fish M., and Nusse R. Genetic evidence that Drosophila frizzled controls planar cell polarity and Armadillo signaling by a common mechanism. Genetics 171 4 (2005) 1643-1654
12. Habas R., Dawid I.B., and Xi H.e. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 17 (2003) 295-309
13. Firestein G.S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors?. Arthritis Rheum 39 (1996) 1781-1790
14. Sen M., et al. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 46 11 (2002) 2867-2877
15. Schett G., Zwerina J., and David J.P. The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol 4 9 (2008) 473-480
16. Yuasa T., and Iwamoto M.E. Mechanism of cartilage matrix remodeling by Wnt. Clin Calcium 16(6) (2006) 1034-1039
17. Nakamura Y., Nawata M., and Wakitani S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 167 1 (2005) 1-3
18. Cheon H., Boyle D.L., and Firestein G.S. Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis. J Rheumatol 31 11 (2004) 2106-2114
19. Lamb R., Thomson W., Ogilvie E., and Donn R. British Society of Paediatric and Adolescent Rheumatology.Wnt-1-inducible signaling pathway protein 3 and susceptibility to juvenile idiopathic arthritis. Arthritis Rheum 52 11 (2005) 3548-3553
20. Sen M., et.a. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 44 4 (2001) 772-781
21. Issack P.S., Helfet D.L., and Lane J.M. Role of Wnt signaling in bone remodeling and repair. HSS J 4 1 (Feb 2008) 66-70
22. Pinzone J.J., Hall B.M., Thudi N.K., Vonau M., Qiang Y.W., Rosol T.J., and Shaughnessy Jr. J.D. The role of Dickkopf-1 in bone development, homeostasis and disease. Blood (Oct 3 2008) [Electronic publication ahead of print]
23. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E., and Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280 20 (May 2005) 19883-19887
24. Kawano Y., and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116 Pt 13 (July 2003) 2627-2634
25. Daoussis D., Andonopoulos A.P., and Liossis S.N. Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. Semin Arthritis Rheum. (2008 Dec 16) [Electronic publication ahead of print]
26. Polzer K., Zwerina J., Schett G., and Diarra D. Inflammation and destruction of the joints e The Wnt pathway. Joint Bone Spine 75 (2008) 105-107
27. Jin T. The WNT signalling pathway and diabetes mellitus. Diabetologia 51 (2008) 1771-1780
28. Weedon M.N. The importance of TCF7L2. Diabet Med 24 (2007) 1062-1066
29. Grant S.F., Thorleifsson G., Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 3 (2006) 320-323
30. Helgason A., Palsson S., Thorleifsson G., et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39 2 (2007) 218-225
31. Cauchi S., El Achhab Y., Choquet H., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85 7 (2007) 777-782
32. Hayashi T., Iwamoto Y., Kaku K., Hirose H., and Maeda S. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 50 5 (2007) 980-984
33. Cauchi S., Meyre D., Dina C., et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55 10 (2006) 2903-2908
34. Damcott C.M., Pollin T.I., Reinhart L.J., et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55 9 (2006) 2654-2659
35. Scott L.J., Bonnycastle L.L., Willer C.J., et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55 9 (2006) 2649-2653
36. Zhang C., Qi L., Hunter D.J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 55 9 (2006) 2645-2648
37. Groves C.J., Zeggini E., Minton J., et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55 9 (2006) 2640-2644
38. Agalliu I., Suuriniemi M., and Prokunina-Olsson L. Evaluation of a variant in the transcription factor-7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate (2008) (publicação eletrônica)
39. Folson A.R., Pankow J.S., Peacock J.M., et al. Variation in TCF7L2 and increased risk of colon cancer: the atherosclerosis communities (ARIC) study. Diabetes Care (2008) (publicação eletrônica)
40. Burwinkel B., Shanmugam K.S., Hemminki K., et al. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 6 (2006) 268-271